Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of Biomolecular Structure & Dynamics|December 26, 2025
Targeting P-glycoprotein with novel halogenated 4H-pyran-coumarin hybrids: a combined experimental, computational approach to tumor-sensitive and -resistant (breast) cancer cell linesMohamed H Helal, Saad Alrashdi, Heba Alsharif, et al.
ACS Omega|January 15, 2024
Novel Monosulfonated Azo Dyes: Design, Synthesis, and Application as Disperse Dyes on Polyester FabricsNawal H Bahtiti, Walid E Elgammal, Ali A Ali, et al.
Scientific Reports|February 5, 2025
Novel Azo dyes containing a hydrazide-hydrazone moiety for dyeing polyester fabricAli A Ali, Mostafa A Ismail, Walid E Elgammal, et al.
Future Medicinal Chemistry|May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approachesEslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.
Bioorganic Chemistry|March 9, 2025
Unraveling the interaction of pyranocoumarins with P-glycoprotein: Implications for overcoming multidrug resistance in cancer therapyMohamed H Helal, Mosa H Alsehli, Al-Anood M Al-Dies, et al.
Drug Development Research|May 3, 2026
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer ActivityHazem Elkady, Walid E Elgammal, Ibrahim H Eissa, et al.
Bioorganic Chemistry|March 22, 2020
Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisonsAhmed H Halawa, Walid E Elgammal, Saber M Hassan, et al.
Future Medicinal Chemistry|June 16, 2026
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activityWalid E Elgammal, Hazem Elkady, Aisha A Alsfouk, et al.
Future Medicinal Chemistry|April 8, 2025
Design and synthesis of thiadiazoles as anticancer, apoptotic, and VEGFR-2 inhibitorsWalid E Elgammal, Hazem Elkady, Mohammed A Dahab, et al.
RSC Medicinal Chemistry|June 19, 2025
Novel furo[2,3-d]pyrimidine derivatives as PI3K/AKT dual inhibitors: design, synthesis, biological evaluation, and molecular dynamics simulationM A M Abdel Reheim, Walid E Elgammal, Mahmoud S Bashandy, et al.
Pageof 4